Middle East & Africa Neuropathic Pain Market to 2032
Overview
The Middle East & Africa Neuropathic Pain Market is expected to reach a 383.72 USD Billion by 2032 and is projected to grow at a CAGR of 12.98% from 2025 to 2032.
Revenue, 2024 (USD Billion)
202.52
Forecast, 2032 (USD Billion)
383.72
CAGR, 2024 - 2032
12.98%
Report Coverage
Middle East & Africa
Middle East & Africa Neuropathic Pain Market 2018-2032 USD Billion
Middle East & Africa Neuropathic Pain Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 202.52 USD Billion
- Projected Market Size (2032): 383.72 USD Billion
- CAGR (2025-2032): 12.98%
Key Findings of Middle East & Africa Neuropathic Pain Market
- The Middle East & Africa Neuropathic Pain Market was valued at 202.52 USD Billion in 2024.
- The Middle East & Africa Neuropathic Pain Market is likely to grow at a CAGR of 12.98% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Prescription-Based Devices in Mode of Purchase Segment accounted for the largest share of the market with a revenue of 153.47 USD Billion
- The fastest growing segment Peripheral Neuropathy in Pain Type Segment grew Fastest with a CAGR of 15.30% during the forecast period from 2024 to 2032.
Middle East & Africa Neuropathic Pain Market Scope
Middle East & Africa Neuropathic Pain Market Segmentation & Scope
Indication
- Others
- Chemotherapy-Induced Peripheral Neuropathy
- Diabetic Neuropathy
- Spinal Stenosis
End User
- Others
- Ambulatory Surgical Centers
- Home Healthcare
- Hospitals
- Clinics
Distribution Channel
- Others
- Third Party Distribution
- Direct Tenders
Modality
- Stationary
- Portable
Mode of Purchase
- Over-The-Counter Devices
- Prescription-Based Devices
Pain Type
- Coccydynia
- Trigeminal Neuralgia
- Foot Pain
- Others
- Entrapment Neuropathy
- Post Traumatic Neuropathy
- Post Herpetic Neuralgia (PHN)
- Phantom Limb Pain
- Peripheral Neuropathy
Technology
- Respiratory Electrical Stimulation
- Transcranial Magnetic Stimulation
- Transcutaneous Electrical Nerve Stimulation
Type
- Transcutaneous Electrical Nerve Stimulation (TENS) Devices
- External Peripheral Nerve Stimulation
- Spinal Cord Stimulation (SCS) Devices
Product Type
- Non-Rechargeable
- Rechargeable
Procedure
- Invasive
- Non-Invasive
Middle East & Africa Neuropathic Pain Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2020 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 202.52 USD Billion |
| Market Value in 2032 | 383.72 USD Billion |
| CAGR (2025-2032) | 12.98% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Indication,End User,Distribution Channel,Modality,Mode of Purchase,Pain Type,Technology,Type,Product Type,Procedure |
Regional Insights:
-
Leading Market (2024-2032): Middle East & Africa, leading in terms of revenue 202.52 USD Billion in 2024
- Key Country: South Africa, leading in terms of revenue with value of 60.78 USD Billion in 2024.
Segments and Scope
-
Middle East & Africa Neuropathic Pain Market to 2032, By Indication
- Spinal Stenosis is the largest segment in Middle East & Africa Neuropathic Pain Market to 2032 with a revenue of 84.16 USD Billion in the year 2024.
- Diabetic Neuropathy is the Fastest growing segment in Middle East & Africa Neuropathic Pain Market to 2032 with a Growth rate of 12.79 % in forecast period 2025-2032.
-
Middle East & Africa Neuropathic Pain Market to 2032, By End User
- Clinics is the largest segment in Middle East & Africa Neuropathic Pain Market to 2032 with a revenue of 66.47 USD Billion in the year 2024.
- Hospitals is the Fastest growing segment in Middle East & Africa Neuropathic Pain Market to 2032 with a Growth rate of 13.70 % in forecast period 2025-2032.
-
Middle East & Africa Neuropathic Pain Market to 2032, By Distribution Channel
- Direct Tenders is the largest segment in Middle East & Africa Neuropathic Pain Market to 2032 with a revenue of 133.37 USD Billion in the year 2024.
- Direct Tenders is the Fastest growing segment in Middle East & Africa Neuropathic Pain Market to 2032 with a Growth rate of 13.29 % in forecast period 2025-2032.
-
Middle East & Africa Neuropathic Pain Market to 2032, By Modality
- Portable is the largest segment in Middle East & Africa Neuropathic Pain Market to 2032 with a revenue of 131.30 USD Billion in the year 2024.
- Stationary is the Fastest growing segment in Middle East & Africa Neuropathic Pain Market to 2032 with a Growth rate of 12.79 % in forecast period 2025-2032.
-
Middle East & Africa Neuropathic Pain Market to 2032, By Mode of Purchase
- Prescription-Based Devices is the largest segment in Middle East & Africa Neuropathic Pain Market to 2032 with a revenue of 153.47 USD Billion in the year 2024.
- Prescription-Based Devices is the Fastest growing segment in Middle East & Africa Neuropathic Pain Market to 2032 with a Growth rate of 13.16 % in forecast period 2025-2032.
-
Middle East & Africa Neuropathic Pain Market to 2032, By Pain Type
- Peripheral Neuropathy is the largest segment in Middle East & Africa Neuropathic Pain Market to 2032 with a revenue of 45.13 USD Billion in the year 2024.
- Peripheral Neuropathy is the Fastest growing segment in Middle East & Africa Neuropathic Pain Market to 2032 with a Growth rate of 15.30 % in forecast period 2025-2032.
-
Middle East & Africa Neuropathic Pain Market to 2032, By Technology
- Transcutaneous Electrical Nerve Stimulation is the largest segment in Middle East & Africa Neuropathic Pain Market to 2032 with a revenue of 119.14 USD Billion in the year 2024.
- Transcutaneous Electrical Nerve Stimulation is the Fastest growing segment in Middle East & Africa Neuropathic Pain Market to 2032 with a Growth rate of 13.42 % in forecast period 2025-2032.
-
Middle East & Africa Neuropathic Pain Market to 2032, By Type
- Spinal Cord Stimulation (SCS) Devices is the largest segment in Middle East & Africa Neuropathic Pain Market to 2032 with a revenue of 122.99 USD Billion in the year 2024.
- Spinal Cord Stimulation (SCS) Devices is the Fastest growing segment in Middle East & Africa Neuropathic Pain Market to 2032 with a Growth rate of 13.39 % in forecast period 2025-2032.
-
Middle East & Africa Neuropathic Pain Market to 2032, By Product Type
- Rechargeable is the largest segment in Middle East & Africa Neuropathic Pain Market to 2032 with a revenue of 134.86 USD Billion in the year 2024.
- Rechargeable is the Fastest growing segment in Middle East & Africa Neuropathic Pain Market to 2032 with a Growth rate of 13.47 % in forecast period 2025-2032.
-
Middle East & Africa Neuropathic Pain Market to 2032, By Procedure
- Non-Invasive is the largest segment in Middle East & Africa Neuropathic Pain Market to 2032 with a revenue of 143.94 USD Billion in the year 2024.
- Non-Invasive is the Fastest growing segment in Middle East & Africa Neuropathic Pain Market to 2032 with a Growth rate of 13.13 % in forecast period 2025-2032.
Middle East & Africa Neuropathic Pain Market Company Share Analysis
| Company Name |
|
||
| Medtronic | |||
| Omron Healthcare, Inc. | |||
| NEVRO CORP. | |||
| Integer Holdings Corporation | |||
| Boston Scientific Corporation or its affiliates | |||
Middle East & Africa Neuropathic Pain Market Geographical Sales Distribution, 2018-2032 USD Billion
Middle East & Africa Neuropathic Pain Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Middle East & Africa Neuropathic Pain Market is segmented based on Segmentation Indication,End User,Distribution Channel,Modality,Mode of Purchase,Pain Type,Technology,Type,Product Type,Procedure.
Middle East & Africa Neuropathic Pain Market was valued at USD 202.52(Revenue in USD Billion) in 2020.
Middle East & Africa Neuropathic Pain Market is projected to grow at a CAGR of 12.98% during the forecast period of 2024 to 2032.
The Prescription-Based Devices segment is expected to dominate the Middle East & Africa Neuropathic Pain Market, holding a largest market share of 153.47 USD Billion in 2024
Middle East & Africa Neuropathic Pain Market Scope
Middle East & Africa Neuropathic Pain Market Segmentation & Scope
Indication
- Others
- Chemotherapy-Induced Peripheral Neuropathy
- Diabetic Neuropathy
- Spinal Stenosis
End User
- Others
- Ambulatory Surgical Centers
- Home Healthcare
- Hospitals
- Clinics
Distribution Channel
- Others
- Third Party Distribution
- Direct Tenders
Modality
- Stationary
- Portable
Mode of Purchase
- Over-The-Counter Devices
- Prescription-Based Devices
Pain Type
- Coccydynia
- Trigeminal Neuralgia
- Foot Pain
- Others
- Entrapment Neuropathy
- Post Traumatic Neuropathy
- Post Herpetic Neuralgia (PHN)
- Phantom Limb Pain
- Peripheral Neuropathy
Technology
- Respiratory Electrical Stimulation
- Transcranial Magnetic Stimulation
- Transcutaneous Electrical Nerve Stimulation
Type
- Transcutaneous Electrical Nerve Stimulation (TENS) Devices
- External Peripheral Nerve Stimulation
- Spinal Cord Stimulation (SCS) Devices
Product Type
- Non-Rechargeable
- Rechargeable
Procedure
- Invasive
- Non-Invasive
Frequently Asked Questions
The Middle East & Africa Neuropathic Pain Market is segmented based on Segmentation Indication,End User,Distribution Channel,Modality,Mode of Purchase,Pain Type,Technology,Type,Product Type,Procedure.
Middle East & Africa Neuropathic Pain Market was valued at USD 202.52(Revenue in USD Billion) in 2020.
Middle East & Africa Neuropathic Pain Market is projected to grow at a CAGR of 12.98% during the forecast period of 2024 to 2032.
The estimated market value of the Middle East & Africa Neuropathic Pain Market for final year is USD 383.72 (USD Billion).
Middle East & Africa Neuropathic Pain Market Company Profiling
Frequently Asked Questions
The Middle East & Africa Neuropathic Pain Market is segmented based on Segmentation Indication,End User,Distribution Channel,Modality,Mode of Purchase,Pain Type,Technology,Type,Product Type,Procedure.
Middle East & Africa Neuropathic Pain Market was valued at USD 202.52(Revenue in USD Billion) in 2020.
Middle East & Africa Neuropathic Pain Market is projected to grow at a CAGR of 12.98% during the forecast period of 2024 to 2032.
The estimated market value of the Middle East & Africa Neuropathic Pain Market for final year is USD 383.72 (USD Billion).
CHOOSE LICENCE TYPE
- 4200.00
- 3500.00
- 2000.00
- 5500.00
- 8500.00
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.